July 09, 2018
The U.S. Securities and Exchange Commission has renewed its demand for more than $1 million from a onetime biotech chief executive, telling a New Jersey federal court that his attorney confirmed he pocketed illicit proceeds from the sale of company stock.
February 23, 2018
A New Jersey federal judge on Friday said she would not “rubber-stamp” the U.S. Securities and Exchange Commission's demand for more than $1 million from a onetime biotech chief executive without evidence to back up the agency's claims that he pocketed illicit proceeds from the sale of company stock.
February 19, 2015
The CEO of biotechnology company Proteonomix Inc. admitted in New Jersey federal court Thursday that he made $600,000 by funneling millions of Proteonomix shares to companies nominally under his father-in-law's control and then selling them on the open market.